ProMIS™ Neurosciences, Inc. is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).

Biotechnology

ProMIS Neurosciences

Elliot Goldstein

Ernest D. Bush

Johanne Kaplan

Daniel Geffken

Neil Cashman

Gavin T. Malenfant

Dennis Chen

Michael Grundman

David Wishart

Larry Altstiel

The leadership team at ProMIS Neurosciences has experience in a variety of industries, with a focus on finance and accounting. The team has a strong educational background, with degrees from Baruch College and other prestigious institutions.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at ProMIS Neurosciences

Board of Directors

CEO and Executive Team